SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-17-007076
Filing Date
2017-08-08
Accepted
2017-08-08 17:15:45
Documents
1
Period of Report
2017-08-03
Filing Date Changed
2017-08-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT mbvx8k_aug32017.htm 8-K 27065
  Complete submission text file 0001654954-17-007076.txt   28358
Mailing Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121
Business Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001109196 (see all company filings)

IRS No.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37861 | Film No.: 171015675
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1